netilmicin has been researched along with Digestive-System-Neoplasms* in 1 studies
1 other study(ies) available for netilmicin and Digestive-System-Neoplasms
Article | Year |
---|---|
[The use of clindamycin and netilmicin for preventing postoperative wound infection in patients with cancer of the upper respiratory and digestive tracts].
Clindamycin (2.7 g/day) and netilmicin (5.6 mg/kg) were used for 6-10 days in 27 patients with laryngeal and oral cancer versus beta-lactam antibiotics and aminoglycosides received by 56 matched patients to prevent infection of the operative wound. Suppuration was observed in 11.1 and 41.4% of the patients, respectively (p < 0.05), the temperature rose over 38 degrees C in 22.2% and 42.9% of the patients, respectively (p < 0.05). The regimens showed similar toxicity. The findings proved high efficacy of clindamycin combination with netilmicin in infection prophylaxis in patients operated on for upper respiratory and digestive tract cancer. Topics: Carbenicillin; Cefotaxime; Clindamycin; Combined Modality Therapy; Digestive System Neoplasms; Drug Evaluation; Drug Therapy, Combination; Gentamicins; Humans; Netilmicin; Postoperative Care; Preoperative Care; Respiratory Tract Neoplasms; Surgical Wound Infection; Time Factors | 1993 |